Most Read Articles
3 months ago
Patients with Sjögren’s syndrome (SS) appear to manifest symptoms such as dysphagia, with swallowing dysfunction substantially reducing the patient quality of life, a study has shown.
Pearl Toh, 6 months ago
Concomitant statin therapy was associated with an attenuation of tocilizumab (TCZ)-mediated increase in serum lipids in patients with rheumatoid arthritis (RA), according to a recent post hoc analysis of randomized clinical studies.
Jairia Dela Cruz, 5 months ago
Patients with early rheumatoid arthritis (RA) may benefit from the initial addition of certolizumab pegol (CZP) to optimized methotrexate (MTX) therapy, as this strategy potentially prevents joint destruction, according to the results of the phase III C-OPERA* study.
Tristan Manalac, 5 months ago
Joint mobilization, ultrasound therapy and therapeutic exercises may improve the range of motion of the ankle and decrease pain in patients with tibia and fibula fractures after cast removal, reports a study presented at the 7th Association of South-East Asian Pain Societies (ASEAPS) Congress 2017.

Anxiety disorder associated with higher risk of osteoporosis

8 months ago

People with a history of anxiety disorder are more likely to have osteoporosis, according to a Taiwan study presented at the International Osteoporosis Foundation (IOF) Regionals 2016.

“The risk ratios (RRs) are the highest for osteoporosis within 1 year of anxiety disorder diagnosis, but the risk remains statistically significant for more than 1 year,” researchers said.

Using data in the Longitudinal Health Insurance Database 2000 of Taiwan, a population-based retrospective cohort analysis was conducted to assess the association between anxiety disorder and the subsequent development of osteoporosis. Included were 7,098 patients in both the anxiety disorder and no-anxiety groups who were matched according to age and sex between 2000 and 2013.

Researchers calculated the incidence rate and RRs of subsequent new-onset osteoporosis for both cohorts. Cox proportional hazards models were used to assess the effect of anxiety disorder, and the Kaplan-Meier method was applied to estimate the cumulative osteoporosis incidence curves.

Patients in the anxiety disorder cohort had a higher risk of osteoporosis than those in the comparison cohort. In addition, the incidence of newly diagnosed osteoporosis remained significantly increased in all of the stratified follow-up durations (0 to 1, 1 to 5, 5 to 10, ≥10 years).

Patients with anxiety disorder were 1.79 times more likely to get osteoporosis than those without. There was also a significant increase in osteoporotic risk in patients with anxiety disorder who were comorbid with hypertension, diabetes mellitus and chronic liver disease.

Researchers suggested that clinicians should pay particular attention to osteoporotic comorbidities in patients with anxiety disorder.

Editor's Recommendations
Most Read Articles
3 months ago
Patients with Sjögren’s syndrome (SS) appear to manifest symptoms such as dysphagia, with swallowing dysfunction substantially reducing the patient quality of life, a study has shown.
Pearl Toh, 6 months ago
Concomitant statin therapy was associated with an attenuation of tocilizumab (TCZ)-mediated increase in serum lipids in patients with rheumatoid arthritis (RA), according to a recent post hoc analysis of randomized clinical studies.
Jairia Dela Cruz, 5 months ago
Patients with early rheumatoid arthritis (RA) may benefit from the initial addition of certolizumab pegol (CZP) to optimized methotrexate (MTX) therapy, as this strategy potentially prevents joint destruction, according to the results of the phase III C-OPERA* study.
Tristan Manalac, 5 months ago
Joint mobilization, ultrasound therapy and therapeutic exercises may improve the range of motion of the ankle and decrease pain in patients with tibia and fibula fractures after cast removal, reports a study presented at the 7th Association of South-East Asian Pain Societies (ASEAPS) Congress 2017.